Corrigendum to "Assessing cardiac safety in oncology drug development" [Am Heart J 214 (2019) 125-133]

Am Heart J. 2019 Dec:218:133. doi: 10.1016/j.ahj.2019.08.006.

Authors

Jonathan H Seltzer¹, Gary Gintant², Laleh Amiri-Kordestani³, Jack Singer⁴, Luana Pesco Koplowitz⁵, Javid J Moslehi⁶, Ana Barac⁷, Anthony F Yu⁸

Affiliations

¹ ACI Clinical, Bala Cynwyd, PA. Electronic address: jseltzer@aciclinical.com.
² Abbvie, North Chicago, IL.
³ FDA, Silver Spring, MD.
⁴ Washington State University, CTI Biopharma, Seattle, WA.
⁵ DUCK FLATS Pharma, Elbridge, NY.
⁶ Vanderbilt University Medical Center, Nashville, TN.
⁷ Georgetown University/Medstar Health, Washington, DC.
⁸ Memorial Sloan Kettering, New York, NY.

PMID: 31806089
DOI: 10.1016/j.ahj.2019.08.006

No abstract available

Publication types

Published Erratum